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PKR is not obligatory for high-fat diet-induced
obesity and its associated metabolic and
inﬂammatory complications
G.I. Lancaster1, H.L. Kammoun1, M.J. Kraakman1, G.M. Kowalski1,2, C.R. Bruce1,2 & M.A. Febbraio1,3
Protein kinase R (PKR) has previously been suggested to mediate many of the deleterious
consequences of a high-fat diet (HFD). However, previous studies have observed substantial
phenotypic variability when examining the metabolic consequences of PKR deletion.
Accordingly, herein, we have re-examined the role of PKR in the development of obesity and
its associated metabolic complications in vivo as well as its putative lipid-sensing role in vitro.
Here we show that the deletion of PKR does not affect HFD-induced obesity, hepatic steatosis
or glucose metabolism, and only modestly affects adipose tissue inﬂammation. Treatment
with the saturated fatty acid palmitate in vitro induced comparable levels of inﬂammation in
WT and PKR KO macrophages, demonstrating that PKR is not necessary for the sensing of
pro-inﬂammatory lipids. These results challenge the proposed role for PKR in obesity, its
associated metabolic complications and its role in lipid-induced inﬂammation.
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O
besity is associated with a wide array of pathologies,
collectively known as metabolic diseases, which have
signiﬁcant morbidity and mortality. Work over the last
two decades has established that chronic, low-grade inﬂammation
is an important link between obesity and the development
of metabolic diseases1–3. For example, obesity-induced
inﬂammation within speciﬁc tissues contributes to the
development of insulin resistance and type 2 diabetes2,
hepatocellular carcinoma4, atherosclerosis5 and contributes to
altered feeding behaviour, obesity and hypertension6,7.
Obesity-induced adipose tissue inﬂammation has been
extensively characterized (for review see refs 1,2) and plays a
key role in the development of impaired glucose metabolism and
insulin resistance, important developmental stages in the
progression to type 2 diabetes. The development of obesity
initiates a transformation of the immune cell proﬁle within the
adipose tissue, characterized by a reduction in the numbers
of anti-inﬂammatory immune cells8–11, the recruitment of
pro-inﬂammatory immune cells12–16 and the release of pro-
inﬂammatory cytokines such as tumour necrosis factor a (TNFa),
interleukin-1b (IL-1b), IL-6 and interferon g. Classically, it is
considered that speciﬁc pro-inﬂammatory lipids activate the
nuclear factor kB (NF-kB) and JNK signalling pathways within
macrophages, adipose tissue and the liver leading to pro-
inﬂammatory cytokine production, impaired insulin signalling
via insulin receptor substrate 1 serine phosphorylation, impaired
glucose metabolism and insulin resistance2,3. More recent work
points to adipose tissue inﬂammation-induced lipolysis as being a
central mediator of elevated hepatic glucose production and
obesity-induced hyperglycaemia17. Given the importance of
inﬂammation in the development of impaired glucose
metabolism and insulin resistance, considerable effort has been
made in understanding how the nutrient-surplus associated with
obesity, in particular chronically elevated lipids such as fatty
acids, activates pro-inﬂammatory signalling pathways such as
NF-kB and JNK. In this regard, several processes have been
identiﬁed that couple the ‘sensing’ of changes in intra- and extra-
cellular lipid levels to the activation of inﬂammatory signalling
pathways. These include c-Src activation and clustering within
membrane subdomains18, endoplasmic reticulum stress19,20,
the nucleotide-binding domain, leucine-rich repeats containing
family, pyrin domain-containing-3 (NLRP3) inﬂammasome21,
Toll-like receptor 4 (refs 22,23) and protein kinase R (PKR)24.
PKR is best known for its function in the innate immune
system where it plays a key role in the resistance to viral
infection25. However, recent studies have shown that PKR is
activated by chronically elevated levels of speciﬁc nutrients24 and
that the deletion of PKR has a number of effects on whole-body
metabolism including protection against high-fat diet
(HFD)-induced obesity, glucose intolerance, insulin resistance
and inﬂammation24,26,27. More recent studies have identiﬁed
binding of small nucleolar RNAs to PKR following exposure to
the saturated fatty acid palmitate, and have suggested that PKR is
an indirect sensor of nutrient surplus28. However, although
previous studies have concluded that the deletion of PKR
prevents the deleterious consequences of a HFD, there is
nonetheless considerable phenotypic variation observed in the
previous studies that have examined the metabolic consequences
of PKR deletion24,26,27. For example, although initial studies
showed that PKR knockout (KO) mice were profoundly protected
from HFD-induced obesity24,27, more recent studies show no
protection from hyperphagia-induced obesity when PKR KO
mice are crossed to the genetically obese ob/ob background26.
Given the potential importance of PKR as a sensor of chronic
nutrient excess and in mediating the deleterious metabolic
consequences of high fat (HF) feeding, we sought to clarify the
previously described role of PKR in the development of HFD-
induced obesity, impaired glucose metabolism and inﬂammation.
Here we show that the deletion of PKR has no effect on HFD-
induced obesity or the development of impaired glucose
metabolism, and has only a modest effect on adipose tissue
inﬂammation.
Results
Study in non-littermate PKR KO and wild-type (WT) mice.
The PKR KO mice used herein have been backcrossed to the
C57Bl/6 background (greater than 20 generations)29 and have
been used in numerous previous studies to examine the role of
PKR in multiple experimental settings30–32. In preliminary
experiments examining the role of PKR in metabolism, we
compared PKR KO mice with non-littermate WT C57Bl/6 mice.
Following 10 weeks of a HFD, PKR KO mice had a moderately
exacerbated obesity phenotype compared with their WT
counterparts (fat mass¼ 17.9±0.9 g versus 13.1±2.2 g;
Po0.001; for PKR KO, n¼ 7; and WT, n¼ 8, respectively).
These results were opposite to two previous studies that
demonstrate protection from HFD-induced obesity in PKR KO
mice24,27. In attempting to reconcile these discrepant ﬁndings, we
considered that the animal breeding strategy employed may have
contributed to the divergent results of our study and those
published previously24,27. Speciﬁcally, we obtained PKR KO mice
from crosses of mice homozygous for the mutated Eif2ak2 allele
and compared these with C57Bl/6 WT mice. This may have
potentially impacted on the results of our study in several ways:
for example, differences in the gut microbiome, which are
inﬂuenced by the parental lineage and husbandry conditions
within animal houses, can profoundly affect metabolic
phenotypes, and genetic/epigenetic differences that may have
arisen between the two independently maintained lines of mice.
Accordingly, to control for potential genetic or microbiome
differences, we conducted extensive experiments using WT and
PKR KO littermate control mice obtained from crosses of
mice heterozygous for the mutated Eif2ak2 allele. All the
data contained herein were generated using WT and PKR KO
littermate control mice obtained from crosses of mice
heterozygous for the mutated Eaf2ak2 allele.
Loss of PKR does not prevent the development of obesity. WT
and PKR KO mice were fed with either a standard chow diet
(SCD; 12% kJ from fat) or HFD (43% kJ from fat) for a period
of 16 weeks commencing at 6 weeks of age. Compared with
standard chow (SC)-fed mice, HF-fed mice gained signiﬁcantly
more weight over the course of the dietary period (Fig. 1a), an
effect that was attributable to an increase in fat mass (Fig. 1b,c).
However, the loss of PKR did not affect the development of
obesity whatsoever (Fig. 1a,b,d).
Loss of PKR does not improve glucose metabolism. Although
our PKR KO mice did not display an obesity phenotype,
it is not uncommon for glucose intolerance and/or insulin
resistance to be uncoupled from obesity in genetically modiﬁed
mice. Accordingly, we performed oral glucose tolerance tests
(OGTTs) in WT and PKR KO mice following 6 and 16 weeks of
dietary intervention, time points that reﬂect differing levels of
obesity (Fig. 1a,b). Following 6 weeks of the dietary period, mice
fed the HFD were signiﬁcantly glucose intolerant compared with
those fed the SCD (Fig. 2a,c,i). Both fasting plasma insulin
concentrations and the increase in plasma insulin 15min fol-
lowing the administration of the glucose bolus were exacerbated
in HF-fed mice (Fig. 2b,d,k), indicative of systemic insulin
resistance. These data conﬁrm the efﬁcacy of the HFD regimen
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we employed to induce impaired glucose tolerance and insulin
resistance. The loss of PKR, however, neither affected glucose
metabolism nor plasma insulin levels after 6 weeks of either SCD
or HFD (Fig. 2a–d,i,k). Glucose tolerance, fasting plasma insulin
and plasma insulin during the OGTT were further worsened
following 16 weeks of HFD (Fig. 2e–h,j,l). Although the loss of
PKR did not affect glucose tolerance following 16 weeks of either
the SCD (Fig. 2e) or HFD (Fig. 2g), we did observe signiﬁcantly
lower plasma insulin levels in PKR KO mice compared with their
WT counterparts following 16 weeks of HFD (Fig. 2h; genotype
main effect, P¼ 0.018). This effect was primarily driven by the
plasma insulin concentrations during the OGTT (15min
time point) as no signiﬁcant difference was observed between
genotypes in fasting insulin concentrations (Fig. 2l).
Loss of PKR does not improve hepatic steatosis. Hepatic
steatosis is a hallmark of obesity and deletion of PKR was
previously shown to prevent HFD-induced hepatic lipid accu-
mulation24. As expected, we observed a signiﬁcant increase in
hepatic triacylglycerol (TAG) levels following the HFD (Fig. 3a).
However, loss of PKR had no effect on TAG accumulation
(Fig. 3a). We observed a signiﬁcant decrease in fasting plasma-
free fatty acids (Fig. 3b) and an increase in fasting plasma
cholesterol levels (Fig. 3c) following 16 weeks of HFD, neither of
which were affected by the loss of PKR (Fig. 3b,c). Although
plasma TAG levels were unaffected by the HFD, we did, however,
observe a signiﬁcant decrease in plasma TAG levels in PKR KO
mice compared with their WT counterparts (Fig. 3d).
PKR deletion moderately affects adipose tissue inﬂammation.
Adipose tissue immune cell recruitment and inﬂammation are a
hallmark of obesity and are thought to play a critical role in the
development of glucose intolerance and insulin resistance. The
loss of PKR has previously been reported to reduce adipose tissue
inﬂammation24. Although we did not observe a protective effect
of PKR deletion on either the development of obesity or glucose
intolerance, we nonetheless sought to determine whether the loss
of PKR could prevent adipose tissue inﬂammation, as we recently
demonstrated that adipose tissue macrophage recruitment due to
HF feeding could be prevented, in the absence of whole-body
changes in insulin sensitivity33. As expected, mice fed a HFD
displayed many of the hallmarks of adipose tissue inﬂammation
such as macrophage and T-cell recruitment and an increase in the
expression of pro-inﬂammatory cytokine expression (Fig. 4a–d
and Supplementary Figs 1–2). Loss of PKR did not prevent
macrophage recruitment into adipose tissue (Fig. 4c,d), affect
macrophage polarization state (Fig. 4e) or the expression of
pro-inﬂammatory cytokines including Tnf, Il1b and Il6 (Fig. 4c).
A feed forward loop has recently been described in which
obesity promotes monocytosis and neutrophilia, contributing to
enhanced adipose tissue macrophage accumulation34. Although
we observed monocytosis following 16 weeks of HFD, the loss of
PKR was without effect on HFD-induced monocytosis (Fig. 4f
and Supplementary Fig. 3). Neutrophil numbers were not affected
by either the HFD or the loss of PKR (Fig. 4f). However, the loss
of PKR did prevent the recruitment of T cells into the adipose
tissue following 16 weeks of HFD, as demonstrated by both
decreased Cd3g and Ifng gene expression (Fig. 4c) and reduced
numbers of TCRbþ T cells within the adipose tissue as
determined by ﬂow cytometry (Fig. 4d).
Activation of JNK within the adipose tissue is proposed to play
an important role in the development of both inﬂammation and
insulin resistance. Although we and others have previously
observed increased JNK activation in the adipose tissue of HF-fed
mice35,36, in the present study we were unable to observe any
signiﬁcant dietary effect on JNK phosphorylation status (Fig. 4g
and Supplementary Fig. 4) and the loss of PKR was also without
effect on JNK phosphorylation status (Fig. 4g and Supplementary
Fig. 4). It has previously been shown that obesity activates PKR24
and that eIF2a, PKR’s canonical substrate, is also activated by
obesity. Consistent with the previous literature20, we observed a
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Figure 1 | Loss of PKR does not prevent the development of obesity. Total body mass (a), fat mass (b), lean mean (c) and epididymal adipose tissue mass
(d) in WT and PKR KO mice fed either a HFD or SCD for 16 weeks. Ns are 9, 8, 12 and 18 for WT SCD, PKR KO SCD, WT HFD and PKR KO HFD,
respectively. Data are presented as the mean±standard deviation (s.d.). *Po0.001, two-way ANOVA, main effect of diet between SCD and HFD.
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signiﬁcant increase in the phosphorylation of eIF2a in the
adipose tissue of HF-fed mice (Fig. 4h and Supplementary Fig. 4).
Of note, we observed a borderline signiﬁcant decrease in
phosphorylated eIF2a levels in PKR KO animals (two-way
analysis of variance (ANOVA), genotype main effect P¼ 0.05),
suggesting that PKR indeed contributes to eIF2a phosphorylation
status in adipose tissue, irrespective of dietary status (Fig. 4h and
Supplementary Fig. 4). However, and importantly, the relative
increase in eIF2a phosphorylation following the HFD was
nearly identical in both WT and PKR KO mice (Fig. 4h and
Supplementary Fig. 4), demonstrating that PKR plays a minimal
role in the regulation of eIF2a phosphorylation in adipose tissue
following HF feeding. One of eIF2a’s additional three upstream
kinases, such as PKR-like endoplasmic reticulum kinase,
which has previously been shown to be activated in obese
adipose tissue20, is likely responsible for the increased eIF2a
phosphorylation we observed in adipose tissue from HF-fed WT
and PKR KO mice.
PKR deletion does not prevent lipid-induced inﬂammation. As
discussed above, PKR is proposed to be a central component of a
complex that responds to nutrients, promoting inﬂammation in
times of nutrient excess24. Long-chain saturated free fatty acids
(lcSFA) exert pro-inﬂammatory actions via number of
mechanisms, and PKR has previously been shown to be
activated by lcSFA and deletion of PKR prevented lcSFA-
induced inﬂammation24. To test the role of PKR in lcSFA-
induced inﬂammation in vitro, we treated primary bone marrow-
derived macrophages (BMDM) with the lcSFA palmitate for 4 h
and assessed the phosphorylation status of JNK. Although JNK
phosphorylation was markedly increased following treatment
with palmitate, the loss of PKR was without effect on palmitate-
induced JNK phosphorylation (Fig. 5a and Supplementary Fig. 5).
Likewise, palmitate increased eIF2a phosphorylation in WT and
PKR KO BMDM to a similar extent (Fig. 5b and Supplementary
Fig. 5). In a separate set of experiments, we treated WT and PKR
KO BMDM with palmitate for 8 h and assessed the amount of
TNFa and IL-1b released into the cell culture media. Palmitate
treatment increased the concentrations of TNFa and IL-1b in the
media, with WT and PKR KO BMDM releasing comparable
amounts of TNFa and IL-1b (Fig. 5c,d). Inﬂammasomes are
multimeric protein complexes that control the activation of
precursor IL-1b (ref. 37). The role of PKR in inﬂammasome
activation is controversial, with evidence that loss of PKR
prevents inﬂammasome activation38, or has no effect on
inﬂammasome activation39. Given the important role of the
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Figure 2 | Loss of PKR does not improve glucose metabolism in HF-fed mice. Glucose tolerance as assessed by OGTT (a,c,e,g) and plasma
insulin during the OGTT (b,d,f,h), in WT and PKR KO mice after 6 (a–d) and 16 (e–h) weeks of either a SCD (a,b,e,f) or HFD (c,d,g,h). The area under
the curve for the OGTT in all groups at 6 (i) and 16 weeks (j). Fasting plasma insulin concentrations in all groups at 6 (k) and 16 weeks (l). Except for
plasma insulin following 16 weeks of HFD in PKR KO mice where N¼ 17, Ns are 9, 8, 12 and 18 for WT SCD, PKR KO SCD, WT HFD and PKR KO HFD,
respectively. Data are presented as the mean±standard deviation (s.d.). *Po0.001, two-way ANOVA, main effect for time between 0 and 15min.
**Po0.01, two-way ANOVA, main effect for time between 0 and 15min. wP¼0.018, two-way ANOVA, main effect for genotype between WTand PKR KO.
zPo0.001, two-way ANOVA, main effect of diet between SCD and HFD. zzP¼0.01, two-way ANOVA, main effect of diet between SCD and HFD.
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NLRP3 inﬂammasome in mediating obesity-induced
inﬂammation, impaired glucose metabolism and insulin
resistance21, we examined the role of PKR in NLRP3
inﬂammasome activation. Following 3 h of priming with
lipopolysaccharide (LPS), we treated WT and PKR KO BMDM
with the NLRP3 inﬂammasome activators nigericin and ATP. As
expected, LPS ‘primed’ BMDM produced signiﬁcantly more IL-
1b when treated with either nigericin (Fig. 5e) or ATP (Fig. 5f);
however, we observed no differences in IL-1b release between
WT and PKR KO BMDM.
Poly(I:C) does not impair glucose tolerance. In a ﬁnal set
of experiments, we determined whether the injection of
polyinosinic:polycytidylic acid (Poly(I:C)), a synthetic analogue of
double-stranded RNA, and hence an activator of PKR, could
impair glucose tolerance. Based on previous studies that have
examined the cytokine40, physiological41 and behavioural41
responses of mice to Poly(I:C), we injected C57Bl6/J mice with
10mg kg 1 of Poly(I:C) or a sterile saline control 6 h before the
assessment of glucose tolerance by OGTT. As shown in Fig. 6a–c,
Poly(I:C) did not impair glucose tolerance relative to sterile saline.
Discussion
The results of the present study show that the deletion of PKR has
no effect on HFD-induced obesity or the development of
impaired glucose metabolism. Three previous studies from two
independent laboratories have examined the effects of the loss of
PKR on metabolism in vivo24,26,27, and, although each of these
studies has concluded that the deletion of PKR protects against
the deleterious effects of a HFD, there are nonetheless substantial
differences in the phenotypes reported in these previous studies,
highlighting that the role of PKR in vivo in the context of
metabolic disease remains to be fully clariﬁed. In the original
report by Nakamura et al. on the role of PKR in metabolism,
deletion of PKR largely prevented HFD-induced obesity and
decreased fasting plasma insulin and fasting blood glucose
concentrations24. After 6 weeks of HFD, a time point at which
no differences in bodyweight were observed, PKR KO mice had
improved glucose clearance during a GTT compared with WT
mice24. Although PKR KO mice also had improved glucose
tolerance following 14 weeks of HFD, it is important to note that
WT mice were B30% heavier than PKR KO mice at this time
point. As the bolus of glucose administered during the GTT was
relative to bodyweight, the putative improvement in glucose
tolerance may reﬂect the commensurately lower bolus of glucose
administered to the PKR KO mice24. Similarly, although it is
stated that PKR KO mice had improved insulin tolerance, the
difference between the WT and PKR KO mice is primarily
accounted for by alterations in basal glucose levels, with the
hypoglycaemic response to insulin administration similar
between WT and PKR KO mice24; although it should be noted
that PKR KO mice did have improved insulin signalling
responses, suggesting that at least to some extent insulin action
was enhanced in PKR KO mice compared with WT controls24.
PKR KO mice also had reduced adipose tissue inﬂammation
as indicated by the reduced gene expression of a number of
pro-inﬂammatory cytokines as well as markers of macrophage
inﬁltration24. Finally, when fed a SCD, no phenotypic differences
were observed between WT and PKR KO mice24.
In the study by Carvalho-Filho et al.27 PKR KO mice,
regardless of being fed either a SCD or HFD, had fasting blood
glucose concentrations of B3mM (50–60mg dl 1), compared
with B8mM (150mg dl 1) for the WT mice. In mice, a blood
glucose concentration of 3mM represents hypoglycaemia,
indicating that the loss of PKR in this study resulted in a
profound disruption to the control of glucose metabolism.
Although the PKR KO mice in the Carvalho-Filho et al. study
had markedly improved glucose tolerance following a HFD, it is
again important to note that mice were given a bolus of glucose
that was body weight dependent. Because HF-fed WT mice
weighed B50% more than PKR KO mice, it is possible that the
improved glucose tolerance observed in PKR KO mice is
mediated by the reduced bolus of glucose that PKR KO mice
received. However, it should be noted that Carvalho-Filho et al.
show an increase in the glucose infusion rate required to maintain
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euglycaemia during a hyperinsulinaemic-euglycaemic clamp,
indicative of improved insulin sensitivity. Finally, in contrast to
the original report of Nakamura et al.24 Carvalho-Filho et al.
show improved glucose tolerance, and, as noted above, reduced
fasting blood glucose levels, in PKR KO mice fed a SCD.
In a recent study by Nakamura et al.26 PKR KO mice were
backcrossed to the C57Bl/6 background before being intercrossed
with mice heterozygous for the ob (leptin) mutation to generate
PKR KO-ob/ob mice. In contrast with the previously reported
protective effect of PKR deletion on HFD-induced obesity24,27,
ob/ob-PKR KO mice gained identical amounts of weight
compared with ob/ob control mice26. Although fasting blood
glucose levels were reduced in ob/ob-PKR KO mice, fasting
plasma insulin levels were unaltered between ob/ob-PKR KO and
ob/ob control mice26. Furthermore, although it was concluded
that PKR KO-ob/ob mice have improved glucose clearance and
insulin sensitivity, as assessed by glucose and insulin tolerance
tests, respectively, these differences are primarily due to
differences in fasting blood glucose levels26. Based on the data
presented by Nakamura et al.26 the glucose clearance, as inferred
from the area under the curve, and insulin sensitivity, as inferred
from the absolute decrease in the blood glucose concentration
following insulin administration, are similar in PKR KO-ob/ob
mice and ob/ob control mice26. These data suggest that when
crossed to the ob/ob background, the deletion of PKR has little
effect on obesity or insulin sensitivity.
Finally, in agreement with the results reported herein, in a
study examining the contribution of PKR to the decreased food
intake, reduced weight gain and bodyweight loss induced by the
ribotoxic mycotoxin, trichothecene deoxynivalenol, it was shown
that WT and PKR KO mice not receiving deoxynivalenol gained
similar amounts of weight when fed a HFD for 15 weeks42.
It is important to note that two distinct lines of PKR KO mice
have been generated and the studies described above have used
one or the other of these PKR KO mouse lines. The originally
reported PKR KO mouse line was generated by the disruption of
exons 2 and 3 of Eif2ak2 (ref. 29) and the second by disruption of
exon 12 of Eif2ak2 (ref. 43). Henceforth, for convenience, we refer
to these two lines as N-PKR KO29 and C-PKR KO43. In the
present study, we used the N-PKR KO mice on a C57Bl/6 genetic
background, which contrasts with Nakamura et al.24 who used
the C-PKR KO mice on a mixed 129Sv x BALB/c background,
and these differences may account for the phenotypic differences
observed between the two studies. Indeed, differences have been
reported in the signalling responses of cells isolated from C-PKR
KO and N-PKR KO mice to speciﬁc stimuli29,43. However, the
study by Carvalho-Filho et al.27 used the same N-PKR KO mouse
line on the C57Bl/6 genetic background as used herein. It is
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Figure 4 | Loss of PKR does not prevent HFD-induced adipose tissue macrophage recruitment, but ameliorates T-cell recruitment. Inﬂammatory gene
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difﬁcult to reconcile the markedly different phenotypes that were
observed between Carvalho-Filho et al.27 and that reported
herein, although different husbandry conditions between animal
facilities may potentially explain some of the differences. Finally,
Flannery et al.42 also used the N-PKR KO line on the C57Bl/6
genetic background, as used herein, and reported a very similar
effect of PKR deletion on HFD-induced weight gain to that
observed in our study, that is, no effect.
It is important to highlight that while we conclude that the
deletion of PKR does not affect HFD-induced obesity or glucose
metabolism, a conclusion that is at odds with the proposed role of
PKR in metabolic homeostasis, there are nonetheless several
aspects of the phenotype that we describe that are in agreement
with previous reports that claim a protective effect of PKR
deletion. Consistent with Nakamura et al.26 who examined the
effect of PKR deletion in ob/ob mice, we see no effect of PKR
deletion on the development of obesity, fasting plasma insulin
levels or glucose tolerance. Furthermore, both as reported by
Nakamura et al.26 and herein, PKR KO mice had a decrease in
plasma TAG levels. Consistent with the original report by
Nakamura et al.24 we see a modest reduction in adipose
tissue inﬂammation, albeit we did not observe reductions in
macrophage inﬁltration or the expression of classical pro-
inﬂammatory cytokines such as Tnfa and Il1b. In addition,
both in the present study and that by Nakamura et al.24 PKR KO
mice fed a SCD were indistinguishable from their WT
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counterparts. Finally, although we did not observe an
improvement in glucose tolerance following 16 weeks of HFD
in PKR KO mice, plasma insulin levels during the OGTT were
signiﬁcantly lower, indicative of increased insulin sensitivity and
consistent with the original report by Nakamura et al.24
Collectively, the results of previous studies examining the effect
of PKR deletion on obesity, glucose metabolism and insulin
resistance demonstrate substantial phenotypic variability and, in
some instances, relatively modest effects. Our results demonstrate
that the deletion of PKR has no role in HFD-induced obesity and,
at most, only a minor effect on its associated complications such
as adipose tissue inﬂammation and impaired glucose metabolism.
In light of the central role that PKR is postulated to play in
mediating the deleterious effect of a HFD and obesity, the
contribution of PKR to the development of obesity and its
associated complications needs further research.
As the PKR KO mice we used in our studies were extensively
backcrossed to the C57Bl/6 background, in our initial preliminary
studies we compared PKR KO mice with C57Bl/6 WT controls.
Although this is a common experimental approach, it is
nonetheless subject to potential sources of bias, which may
confound the interpretation of experimental results. In our initial
study, PKR KO mice were transferred to our institution at
B4 weeks of age following breeding at a separate institution.
AtB10 weeks of age, these PKR KO mice and C57Bl/6 WT mice
obtained from a colony maintained within our institution
commenced HF feeding. Accordingly, a number of factors
may have inﬂuenced the results of this study, such as genetic/
epigenetic differences, which may have arisen between the
independently maintained C57Bl/6 WT and PKR KO mouse
colonies and differences in the gut microbiome. Accordingly, and
because the results of our initial study contradicted two
previously published reports, we were concerned that the
phenotype we observed may have been the result of factors
independent of the deletion of PKR. To control for potential
genetic, microbiome or other differences, we generated PKR KO
and WT littermates by crossing mice heterozygous for the
mutated Eif2ak2 allele. The differences that we observed between
our initial study and the subsequent study using WT and PKR
KO littermate controls underscores the importance of using
littermate control mice in all studies examining altered metabolic
homeostasis.
It was previously shown that murine embryonic ﬁbroblasts
(MEFs) lacking PKR were resistant to the pro-inﬂammatory
effects of the saturated fatty acid palmitate24. Given that we did
not observe any effect in vivo of PKR deletion on HFD-induced
obesity or glucose metabolism, we next decided to test the
proposed lipid sensing function of PKR by determining if the
loss of PKR compromised the ability of macrophages to respond
to pro-inﬂammatory saturated fatty acids. Unlike MEFs,
macrophages are important pro-inﬂammatory cells in vivo in
the context of obesity where they are proposed to respond to
pro-inﬂammatory lipids. Using primary macrophages, we show
that the deletion of PKR did not prevent the ability of palmitate to
activate JNK or eIF2a or to stimulate the release of the
pro-inﬂammatory cytokines TNFa or IL-1b. Although these
data are consistent with the observed in vivo phenotype of HF-fed
PKR KO mice reported herein, they are nonetheless at odds with
previous ﬁndings24. It is possible that differences in the cell types
used, primary macrophages versus MEFs, or the fact that our
primary macrophages were derived from N-PKR KO mice and
the MEFs used in Nakamura et al. were obtained from C-PKR
KO mice, may account for the differences we observed in the
cellular response to palmitate. Indeed, as noted above, MEFs from
C-PKR KO and N-PKR KO have previously been shown to have
distinct responses to pro-inﬂammatory stimuli29,43.
In conclusion, using a well-established and accepted mouse
model of PKR deletion, we ﬁnd that the loss of PKR has no effect
on the ability of cells to sense pro-inﬂammatory lipids in vitro,
and does not alter the development of HFD-induced obesity or
glucose intolerance in vivo. Although these results contradict the
proposed function of PKR in the regulation of metabolic
homeostasis, our ﬁndings are nonetheless consistent with
numerous aspects of previous studies that have examined the
metabolic consequences of PKR deletion. Given the important
role that PKR is proposed to play in the development of obesity
and its associated metabolic consequences, the role of PKR in the
control of metabolic homeostasis requires further, independent
conﬁrmation.
Methods
Mouse experiments. The PKR KO mice used in the present study were generated
previously29. As discussed above, in the initial preliminary study we used PKR KO
male mice obtained from crosses of mice homozygous for the mutated null Eif2ak2
allele and compared these with age-matched C57Bl/6 WT non-littermate control
male mice. All data shown in Figs 1–5 are from experiments conducted in PKR KO
and WT littermate control mice obtained from crosses of mice heterozygous for the
mutated null Eif2ak2 allele, which were bred and housed at the Alfred Medical
Research and Education Precinct Animal Centre (AMREP PAC). In the Poly(I:C)
experiment described in Fig. 6, 8-week-old male C57Bl6/J mice fed a SCD diet were
used. Mice were housed at 22±1 C on a 12:12 h light/dark cycle and had ad
libitum access to food and water. For all the in vivo experimental procedures
described below, littermate control, male mice were fed either a SCD containing
12% of energy from fat (Meat Free Rat and Mouse Diet; Total digestible energy
14.0MJ kg 1; Specialty Feeds) or a HFD containing 43% of energy from fat
(SF04-001; Total digestible energy 19MJ kg 1; Specialty Feeds) commencing at
6 weeks of age for a total of 16 weeks. The animals were randomly assigned to SCD
or HFD groups in a non-blinded manner. All animal experiments were approved
by the AMREP animal ethics committee and were performed in accordance with
National Health and Medical Research Council (NHMRC) of Australia Guidelines
for Animal Experimentation.
Oral glucose tolerance tests. Following a 5-h fast, glucose tolerance was
assessed by the oral administration of 2 g of glucose per kg of lean mass. Before
the administration of glucose and at the indicated time points post glucose
administration, blood was collected from the tip of the tail and blood glucose
concentrations were determined using a glucometer (Accu-Check, Roche).
Additional blood samples were collected at 0 and 15min following glucose
administration and the plasma obtained for the determination of insulin
concentrations.
For the Poly(I:C) (Invivogen; LMW Poly(I:C)) experiments described in Fig. 6,
4 g of glucose per kg of lean mass was administered. Poly(I:C) reconstituted in
sterile saline or the sterile saline vehicle alone were injected intraperitoneally 6 h
before the OGTT. To minimize disturbances to the mice, mice were fasted 6 h
before the OGTT, that is, immediately following Poly(I:C) or sterile saline
injection. The OGTT was conducted as described above.
Body composition. Mice were weighed to determine total body mass and fat and
lean mass were determined using an EchoMRI 4-in-1 (Echo Medical Systems).
Plasma insulin. Plasma insulin concentrations were determined using a mouse
ultrasensitive plasma insulin ELISA (ALPCO). Where required, samples were
diluted according to the manufacturer’s instructions.
WT and PKR KO primary BMDM. Bone marrow-derived macrophages were
generated from bone marrow isolated from the hind limbs of 8-week-old male,
PKR KO and WT littermate control mice. Cells were cultured in RPMI media
containing 15% fetal bovine serum, 20% L929-cell conditioned media and 1%
penicillin/streptomycin. On the day before experimentation, media were changed
to RPMI containing 5% fetal bovine serum and 2% (w/v) bovine serum albumin
(BSA; A6003, Sigma). Palmitate (P0500; Sigma-Aldrich) was dissolved in ethanol at
100mM and conjugated to BSA-containing media with gentle rocking at 37 C at a
ﬁnal concentration of 1mM. The vehicle contained both BSA and ethanol. For
inﬂammasome experiments, BMDM were primed with LPS (Invivogen) at a
concentration of 100 ngml 1 for 3 h before treatment with either Nigericin
(10 mM) or ATP (4mM; Sigma-Alrdich) for 0.5 h.
TNFa and IL-1b ELISAs. Levels of TNFa (DY410) and IL-1b (DY401) in cell
culture supernatants were assessed by DuoSet ELISA (R&D Systems).
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Immunoblotting. Epididymal white adipose tissue (WAT) was collected following
dissection and a portion was snap frozen in liquid nitrogen. Approximately 50mg
of WAT was homogenized in lysis buffer containing HEPES (20mM), EGTA
(2mM), b-glycerophosphate (50mM), dithiothreitol (0.1mM), Na3VO4 (0.1mM),
NaF (1mM), phenylmethylsulphonyl ﬂuoride (1mM), protease inhibitor cocktail
(Sigma; P8340) and Phosphatase Inhibitor Cocktail 2 (Sigma; P5726). Lysates were
kept on ice until being spun at 16,000g for 20min at 4 C, the supernatant collected
and protein concentrations determined using the BCA method (ThermoScientiﬁc).
Twenty micrograms of total protein were solubilized in Laemmli buffer and heated
at 95 C for 5min. For BMDM, cells were washed twice with ice-cold PBS and then
scraped in ice-cold lysis buffer before samples were prepared as described above.
Proteins were resolved by SDS–polyacrylamide gel electrophoresis, transferred to
0.2 mm nitrocellulose membranes (Bio-Rad), blocked in 5% skim milk, washed in
tris-buffered saline and tween 20 (TBST) and incubated in primary antibodies
overnight at 4 C. The molecular weight ladder used was the Precision Plus Protein
Standards (#161-0373; Bio-Rad). The following primary antibodies were used at
1:1,000: pJNK (Cell Signaling, 9251), tJNK (Cell Signaling, 9258), peIF2a (Cell
Signaling. 3597), teIF2a (Cell Signaling, 9722), PKR (Santa Cruz, sc-6282) and a-
tubulin (Sigma, T5168). Following incubation in primary antibody membranes
were washed in TBST and incubated in either rabbit (NA934V, Anti-Rabbit IgG-
HRP, GE Healthcare) or mouse (NXA931, Anti-Mouse IgG-HRP, GE Healthcare)
secondary antibodies for 1 h at room temperature. Following a ﬁnal wash, signals
were detected by chemiluminescence (ThermoScientiﬁc, 34095 and 34080) and
speciﬁc bands quantiﬁed using Quantity One (Bio-Rad).
Flow cytometry. For ﬂow cytometry, WAT was dissected and placed in PBS before
being ﬁnely minced in PBSþ 0.1% BSA containing collagenase B (Roche). After
incubation at 37 C for 45min, a 10 volume of PBSþ 0.1% BSA was added to the
homogenate before being spun (800g for 15min). The cell pellet was washed a
further 2 in PBSþ 0.1% BSA and a single-cell suspension was prepared for
antibody staining. Fluorochrome-conjugated antibodies diluted 1/200 in
PBSþ 0.1% BSA against the following antigens were used for ﬂow cytometry:
CD45 (30-F11; total leukocytes) and Ly6-C/G (RB6-8C5) were from BD
Pharmingen; CD19 (eBio 1D3; B cells), TCRb (H57-597; T cells), F4/80
(BM8; macrophages), CD11c (N418; M1 macrophages), CD206 (C068C2; M2
macrophages) and CD115 (AFS98) were from eBiosciences. Flow cytometry was
performed on a FACS Canto II running FACS Diva software. Representative FACS
plots of CD45þ cells are shown in Supplementary Fig. 1 (WT and PKR KO fed
SCD) and Supplementary Fig. 2 (WT and PKR KO fed HFD). In Supplementary
Fig. 2, F4/80þ cells were gated for subsequent analysis of expression of CD206 and
CD11c (middle two panels).
Blood leukocytes. Whole blood was collected into tubes containing EDTA and
immediately incubated on ice. All subsequent steps were performed on ice. Twenty
microlitres of blood was used for total cell counting by an automated haematology
analyser (XS-1000i, Sysmex Corporation). Red blood cells were lysed (BD pharm
Lyse; BD Biosciences) and white blood cells centrifuged, washed and resuspended
in HBSS (0.1% BSA (w/v), 5mM EDTA). Cells were stained with appropriate
ﬂuorochrome-conjugated antibodies diluted 1/200. Monocytes were identiﬁed as
CD45hiCD115hi, before being further subdivided into Ly6-Chi and Ly6-Clo.
Neutrophils were identiﬁed as CD45hiCD115loLy6-C/G (Gr1)hi. Samples were
analysed on a FACS Canto II (BD Biosciences) and data were analysed using
FlowJo software. The ﬂow cytometry gating strategy we employed was as exactly as
per that previously described in Nagareddy et al.34 Representative FACS plots of
CD45hi cells are shown in Supplementary Fig. 3.
Gene expression. RNA was extracted from B50mg of epididymal WAT using
Trizol (Invitrogen) and total RNA measured using the ND-1000 NanoDrop
Spectrophotometer (Thermo Scientiﬁc). RNA samples were treated with DNase I
(Invitrogen) and cDNA generated using the Tetro cDNA synthesis kit (Bioline).
Gene expression studies were performed by RT–PCR using TaqMan primers
and probes for genes of interest and 18S rRNA (Applied Biosystems). The
following TaqMan primer probe sets were used: Emr1—Mm00802530_m1;
Itgax—Mm00498698_m1; Tnf—Mm00443258_m1; Il1b—Mm00434228_m1;
Ccl2—Mm00441242_m1; Cd3g—Mm00438095_m1; Ifng—00801778_m1;
Il6—Mm00446190_m1; Elane—Mm01168928_g1; 18S—4310893E. Twenty
nanograms of cDNA was used per reaction. The comparative CT method was used
to quantify results from RT–PCR.
Lipids. Plasma TAG (Roche Diagnostics), NEFA (NEFA-C kit; Wako Chemicals)
and cholesterol (Wako) were determined enzymatically using colorimetric assays
accordingly to the manufacturer’s instructions. Liver TAG were assessed following
the extraction of total lipids from B50mg of the liver. Brieﬂy, liver was homo-
genized in 2:1 chloroform/methanol and shaken for 1 h at room temperature.
Following the addition of H2O samples were spun (2,000 r.p.m. for 10min), the
lower chloroform phase collected, dried under nitrogen and the extract dissolved in
ethanol before the determination of TAG concentrations (Roche Diagnostics).
Genotyping. Mice were initially genotyped at 3 weeks of age and assigned to
appropriate groups. Following completion of the dietary period we re-genotyped all
animals to conﬁrm mice had been assigned to the correct groups. Genotyping of
tail samples was performed using a forward primer common to both the WT and
mutated Eif2ak2 allele (50-GTGGTGGGTTGGAAACACCAGATCTGATG-30) and
reverse primers speciﬁc for the WT (50-CCTGGCCCTAACTACATCTTTCCTG
ATG-30) and mutated (PKR KO; 50-CCCGATTCGCAGCGCATCGCCTTCT
ATC-30) Eif2ak2 alleles. DNA was extracted from mouse tails using the MyTaq
Extract-PCR kit (Bioline) according to the manufacturer’s instructions. The fol-
lowing cycling conditions were used: 1 cycle of 3min at 95 C followed by 35 cycles
of 15 s at 95 C, 15 s at 70 C, 20 s at 72 C followed by a ﬁnal step at 72 C for
5min. Products were resolved on a 1% agarose gel containing ethidium bromide.
Sample sizes and exclusion of mice. Power calculations were not performed.
Sample sizes were based on experimental feasibility as well as prior knowledge of
statistical power from our own experience and previously published work. At the
start of the study, 9, 8, 12 and 18 animals were assigned to WT SCD, PKR KO SCD,
WT HFD and PKR KO HFD, respectively. Exclusion of mice: In Fig. 2h, one mouse
was excluded from the PKR KO HFD group as both the 0 and 15min samples were
greater than 3s.d. from the group mean. In Fig. 4b,d,e, only a subset of animals was
used for ﬂow cytometry and no data were excluded from this analysis. In Fig. 4a,
one mouse from the PKR KO SCD was excluded because of poor RNA yield
following RNA isolation. In Fig. 4c, four mice were excluded from the PKR KO
HFD group because of poor RNA yield following RNA isolation. An additional 1–3
mice were excluded from the PKR KO HFD group in Fig. 4c where the expression
of the ‘housekeeping’ gene 18S was greater than 3 s.d. from the mean.
Statistical analysis. Statistical analysis was conducted using IBM SPSS Statistics
Version 22. Statistical signiﬁcance was calculated by independent samples t-test,
two-way ANOVA or two-way repeated-measures ANOVA as appropriate. Gene
expression data were log transformed before statistical analysis because it was
abnormally distributed. Data throughout the paper are shown as mean±the
standard deviation (s.d.). A P value of less than 0.05 was considered statistically
signiﬁcant.
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